Difficulty: Medium
Average Score: 76%
Testbank
A patient with schizophrenia is being treated with olanzapine (Zyprexa) 10 mg daily. The patient asks the nurse how this medicine works. The nurse explains that the mechanism by which the olanzapine controls the patient's psychotic symptoms is believed to be
Correct answer
D
Rationale
Blocking dopamine receptors in the brain.
Olanzapine is an atypical antipsychotic that primarily works by blocking dopamine D2 receptors, which helps to reduce the psychotic symptoms associated with schizophrenia. This action is crucial in managing the disorder, as excess dopamine activity is linked to the manifestation of psychotic symptoms.
A: Increasing the amount of serotonin and norepinephrine in the brain. This option is misleading because while serotonin and norepinephrine may play roles in mood regulation, olanzapine's primary mechanism involves dopamine receptor blockade, not increasing these neurotransmitters.
B: Decreasing the amount of an enzyme that breaks down neurotransmitters. This option does not apply here, as olanzapine does not primarily function by altering enzyme levels but rather by directly blocking dopamine receptors to mitigate psychotic symptoms.
C: Normalizing the levels of serotonin, norepinephrine, and dopamine. This option inaccurately suggests a balancing effect on multiple neurotransmitters, while olanzapine's main therapeutic action specifically targets dopamine receptor blockade to alleviate symptoms of schizophrenia.
Olanzapine is an atypical antipsychotic that primarily works by blocking dopamine D2 receptors, which helps to reduce the psychotic symptoms associated with schizophrenia. This action is crucial in managing the disorder, as excess dopamine activity is linked to the manifestation of psychotic symptoms.
A: Increasing the amount of serotonin and norepinephrine in the brain. This option is misleading because while serotonin and norepinephrine may play roles in mood regulation, olanzapine's primary mechanism involves dopamine receptor blockade, not increasing these neurotransmitters.
B: Decreasing the amount of an enzyme that breaks down neurotransmitters. This option does not apply here, as olanzapine does not primarily function by altering enzyme levels but rather by directly blocking dopamine receptors to mitigate psychotic symptoms.
C: Normalizing the levels of serotonin, norepinephrine, and dopamine. This option inaccurately suggests a balancing effect on multiple neurotransmitters, while olanzapine's main therapeutic action specifically targets dopamine receptor blockade to alleviate symptoms of schizophrenia.